Feb 5, 2019ATXA attends LSX World CongressATXA Therapeutics is excited to be in #London for #LSXWorld Congress 2019. #PAH #SMEs@EU_H2020 @H2020SME @Entirl @NovaUCD
ATXA Therapeutics is excited to be in #London for #LSXWorld Congress 2019. #PAH #SMEs@EU_H2020 @H2020SME @Entirl @NovaUCD
ATXA Therapeutics Publishes Results of Phase 1 First-in-Human Study Evaluating the Safety & Tolerability of NTP42 in Healthy Volunteers
